Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Benson

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
AIDS (London, England)|March 1, 1997
Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infectionR E Chaisson, P Keiser, M Pierce, et al.
The Journal of Infectious Diseases|April 14, 2000
Effects of Mycobacterium avium complex-infection treatment on cytokine expression in human immunodeficiency virus-infected persons: results of AIDS clinical trials group protocol 853R D MacArthur, M M Lederman, C A Benson, et al.
Medical Microbiology and Immunology|June 1, 1997
The efficacy and safety of Skinner herpes simplex vaccine towards modulation of herpes genitalis; report of a prospective double-blind placebo-controlled trialG R Skinner, M E Turyk, C A Benson, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 17, 1999
Predictors for multidrug-resistant tuberculosis among HIV-infected patients and response to specific drug regimens. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG), National Institutes for HealthE E Telzak, K D Chirgwin, E T Nelson, et al.
Annals of Internal Medicine|December 15, 1994
Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study TeamR E Chaisson, C A Benson, M P Dube, et al.
AIDS Patient Care and Stds|July 11, 2001
Toward a definition of HIV expertise: a survey of experienced HIV physiciansB Gerbert, J C Moe, M S Saag, et al.
AIDS (London, England)|July 1, 1997
Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patientsK R Fowke, R D'Amico, D N Chernoff, et al.
Journal of Acquired Immune Deficiency Syndromes|October 11, 1992
Pneumocystis carinii choroiditis in patients with AIDS: clinical features, response to therapy, and outcomeB E Sha, C A Benson, T Deutsch, et al.
The New England Journal of Medicine|September 7, 1995
Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study GroupW L Drew, D Ives, J P Lalezari, et al.
The Journal of Infectious Diseases|September 1, 1993
A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. AIDS Clinical Trials Group and Cytomegalovirus Cooperative Study GroupS A Spector, T Weingeist, R B Pollard, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
AIDS (London, England)|March 1, 1997
Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infectionR E Chaisson, P Keiser, M Pierce, et al.
The Journal of Infectious Diseases|April 14, 2000
Effects of Mycobacterium avium complex-infection treatment on cytokine expression in human immunodeficiency virus-infected persons: results of AIDS clinical trials group protocol 853R D MacArthur, M M Lederman, C A Benson, et al.
Medical Microbiology and Immunology|June 1, 1997
The efficacy and safety of Skinner herpes simplex vaccine towards modulation of herpes genitalis; report of a prospective double-blind placebo-controlled trialG R Skinner, M E Turyk, C A Benson, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 17, 1999
Predictors for multidrug-resistant tuberculosis among HIV-infected patients and response to specific drug regimens. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG), National Institutes for HealthE E Telzak, K D Chirgwin, E T Nelson, et al.
Annals of Internal Medicine|December 15, 1994
Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study TeamR E Chaisson, C A Benson, M P Dube, et al.
AIDS Patient Care and Stds|July 11, 2001
Toward a definition of HIV expertise: a survey of experienced HIV physiciansB Gerbert, J C Moe, M S Saag, et al.
AIDS (London, England)|July 1, 1997
Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patientsK R Fowke, R D'Amico, D N Chernoff, et al.
Journal of Acquired Immune Deficiency Syndromes|October 11, 1992
Pneumocystis carinii choroiditis in patients with AIDS: clinical features, response to therapy, and outcomeB E Sha, C A Benson, T Deutsch, et al.
The New England Journal of Medicine|September 7, 1995
Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study GroupW L Drew, D Ives, J P Lalezari, et al.
The Journal of Infectious Diseases|September 1, 1993
A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. AIDS Clinical Trials Group and Cytomegalovirus Cooperative Study GroupS A Spector, T Weingeist, R B Pollard, et al.
Pageof 8